Purchase Order HHSN269201700755P
Award Date 9/22/17
Potential Completion Date 9/21/18
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Illumina Inc. for $5,883.78 on November 28, 2017, with completion targeted for December 19, 2017. Performance takes place in Bethesda, Maryland. The order covers sequencing reagents, consumables, or related biotechnology products under firm fixed price terms. No set-aside applied.</p>
- The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $22,445.10 on June 12, 2019, with an ultimate completion date of September 27, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order is firm fixed price for commercial sequencing reagents, consumables, or related biotechnology products consistent with Illumina's core federal portfolio in analytical laboratory instrumentation and in vitro diagnostic substances.
- The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $20,298.00 on July 20, 2018, with an ultimate completion date of August 1, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order procures sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product lines for DNA and RNA analysis supporting NIH research and diagnostic operations. The firm fixed price purchase order represents a...
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $12,875.00 on November 16, 2018, with completion targeted for November 17, 2019. No set-aside applied. Place of performance is Bethesda, Maryland. The order procures sequencing reagents, consumables, or related biotechnology supplies on a firm fixed price basis. The award carries no small business designation.</p>
- <p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. for $19,112.76 on July 17, 2019, with an ultimate completion date of October 31, 2019. The order is a firm fixed price procurement with no set-aside. Work is performed in San Diego, California. The purchase order covers sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product portfolio serving federal research and diagnostic agencies.</p>
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $10,752.18 on July 3, 2018. The order, placed under firm fixed pricing with no set-aside, calls for sequencing-related products and services. Place of performance is San Diego, California. The order carried an ultimate completion date of July 3, 2018.</p>
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $75,560.00 on March 27, 2018, with ultimate completion on April 28, 2019. Place of performance is Bethesda, Maryland. The order calls for DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software under firm fixed price. No set-aside was used.</p>
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $13,419.16 on July 25, 2018, with ultimate completion on August 8, 2018. Work is performed in San Diego, California. The order procures sequencing reagents, consumables, or related bioinformatics products on a firm fixed price basis. No set-aside category was applied.</p>
- <p>NIH Clinical Center awarded a purchase order to Illumina Inc. for $13,120.06 on July 12, 2019, with completion by July 31, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. The specific commodity or service detail is not disclosed in the source; the award follows Illumina's established pattern of supplying sequencing instruments, reagents, consumables, and bioinformatics software to federal health and research agencies.</p>
- <p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. for $9,947.04 on June 20, 2017, with completion by July 14, 2017. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no set-aside applied.</p>
The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc., valued at $9,008.64, on September 22, 2017, for firm fixed price acquisition of sequencing reagents and consumables. Place of performance is Bethesda, Maryland. The order is scheduled for ultimate completion on September 21, 2018. No set-aside was used.
Generated 8/1/26, 10:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 9/21/17 |